Back
Moderna Quote, Financials, Valuation and Earnings
Sponsored
MRNA
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
MRNA
Moderna
Last Price:
$39.44
Seasonality Move:
9.23%
7 Day Trial
ALL ACCESS PASS
$
7
The Trump Nuclear MEGA-Boom!
Here's why nuclear stocks are expected to skyrocket under Trump's second term.Moderna Price Quote
$39.44
+0.05 (+-0.3%)
(Updated: December 21, 2024 at 5:37 AM ET)
Moderna Key Stats
Sell
6
Moderna (MRNA)
is a Sell
Day range:
$39.12 - $40.83
52-week range:
$35.80 - $170.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.01
P/B ratio:
1.27%
Volume:
35M
Avg. volume:
10.1M
1-year change:
-54.3%
Market cap:
$15.2B
Revenue:
$6.8B
EPS:
$-5.82
How Much Does Moderna Make?
Data Unavailable
Is Moderna Growing As A Company?
Data Unavailable
Moderna Stock Price Performance
What Is Moderna 52-Week High & Low?
Moderna Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Moderna?
Data Unavailable
Is Moderna Cash Flow Positive?
Data Unavailable
Moderna Return On Invested Capital
Data Unavailable
Moderna Earnings Date & Stock Price
-
What Is Moderna's Stock Price Today?A single share of MRNA can be purchased today for 39.39
-
What Is Moderna’s Stock Symbol?
-
When Is Moderna’s Next Earnings Date?The next quarterly earnings date for Moderna is scheduled on February 21, 2025
-
When Is MRNA's next ex-dividend date?Moderna's next ex-dividend date is December 21, 2024
-
How To Buy Moderna Stock?You can buy Moderna shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Moderna Competitors
Moderna Dividend Yield
Data Unavailable
Moderna Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 101.55% |
Revenue: | 3.81% | 49.32% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 12 |
Sell Recommendations: | 1 |
Price Target: | 127.09 |
Upside from Last Price: | 222.65% |
Major Shareholders
Data Unavailable